|
|
||||||||
B Expression1




*
Department of Cardiothoracic Surgery and
Division of Immunology and Transplantation Biology, Department of Pediatrics, Stanford University, Stanford, CA 94305
A synthetic peptide corresponding to residues 6579 of the
helix of the
-chain of the class II HLA molecule DQA03011 (DQ
6579) inhibits the proliferation of human T lymphocytes in an allele
nonrestricted manner. By using microarray technology, we found that
expression of 29 genes was increased or decreased in a human CTL cell
line after treatment with DQ 6579. This study focuses on one of these
genes, I
B-
, whose expression is increased by DQ 6579. I
B
proteins, including I
B-
and I
B-
, are increased in T cells
treated with DQ 6579. Nuclear translocation of the NF-
B subunits
p65 and p50 is decreased in T cells after treatment with DQ 6579,
while elevated levels of p65 and p50 are present in cytosol. DQ 6579
inhibits the degradation of I
B-
mRNA and inhibits the activity of
I
B kinase. These findings indicate that the DQ 6579 peptide
increases the level of I
B proteins, thereby preventing nuclear
translocation of the transcription factor, NF-
B, and inhibiting T
cell proliferation.
This article has been cited by other articles:
![]() |
M. Cohen-Lahav, S. Shany, D. Tobvin, C. Chaimovitz, and A. Douvdevani Vitamin D decreases NF{kappa}B activity by increasing I{kappa}B{alpha} levels Nephrol. Dial. Transplant., April 1, 2006; 21(4): 889 - 897. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dong, S.-C. Lyu, A. M. Krensky, and C. Clayberger DQ 65-79, A Peptide Derived from HLA Class II, Mimics p21 to Block T Cell Proliferation J. Immunol., November 15, 2003; 171(10): 5064 - 5070. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |